| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6061690 | Annals of Allergy, Asthma & Immunology | 2015 | 5 Pages |
Abstract
Pentraxin 3 sputum levels are increased in patients with COPD and has good power to discriminate these patients from patients with asthma and healthy individuals.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Fabiano L. MD, PhD, Emilio MD, PhD, Tulia MD, Edelton F. MD, PhD, José T. MSc, Leila J.M. MD, PhD, Felipe MD, PhD, Cristiane C. MSc, Marcia M.M. MD, PhD,